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Background: This retrospective observational chart review evaluated the use of the MyChart® 
patient portal as a viable tool for engaging patients. Engagement was measured as fewer missed 
appointments (no-shows and same-day cancellations).  
Objectives: To determine who uses the MyChart® patient portal in a chronically ill population of 
adult patients with diabetes and assess the association of portal use with missed appointments.   
Methods: The medical records of adult patients (18-80) with a diagnosis of Type 1 and/or Type 
2 Diabetes Mellitus (DM) were reviewed (N=7,795). The efficacy of the MyChart® patient portal 
 5 
at reducing missed appointments was assessed by comparing patients who use the portal 
(evidenced by two or more log-ins during the study period) to those who do not.  
Results: In this study, 43.7% of adult patients with diabetes used a portal account. Portal users 
were predominantly female, non-Black, married, non-smokers, and had at least one of the 
comorbidities often associated with diabetes (hypertension, hyperlipidemia, and/or obesity). 
Portal users were on average 58.8 years old. Use of the MyChart® patient portal was 
independently associated with a reduced no-show rate (4.7% for portal users compared to 12.4% 
for nonusers). However, when patients who activated a portal account during the study period 
were subjected to a within-subjects analysis, the mean missed appointment percentage was not 
statistically significantly different when patients had an activated portal account compared to 
when they did not. Thus, the portal may be a useful tool for engaging chronically ill patients but 
it is only one component to appointment arrivals.  
Conclusion: Conclusions from this study are limited given the retrospective design. 
Nonetheless, the findings suggest that the patient portal is effective at engaging chronically ill 
patients and thus warrants greater merit. The portal may also be a useful tool for reducing missed 
appointments in patients with chronic illness who would greatly benefit from appointment 
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Background and Need 
Since the turn of the 20th century, the field of medicine has been based upon a 
paternalistic model, where it is assumed that the doctor knows best. In the paternalistic model, 
the physician plays a parental role, and serves as the driver of the patient’s health. A patient 
comes to the doctor with health concerns; the doctor uses his or her skills to determine the 
patient’s medical condition and/or stage in the disease process, and then decides the treatment 
plan that is in the patient’s best interest with limited patient participation (Emanuel & Emanuel, 
1992). This model is in stark contrast to what is now recognized as a superior delivery model that 
partners patients with their care team: shared-decision making. Shared-decision making is 
founded upon the concept of patient-centered healthcare, which enables and encourages patients 
to take an active role in the management of their own health (AHRQ, n.d.).  
Patient-centered healthcare has been a source of intense discussion since the Institute of 
Medicine (IOM) identified the concept as one of six aims necessary for a new 21st century health 
system (IOM, 2000). In Crossing the Quality Chasm, the IOM (2000) defines patient-centered 
healthcare as “care that is respectful of and responsive to individual patient preferences, needs, 
and values, and ensuring that patient values guide all clinical decisions” (para.8). Put simply, 
patient-centered care is grounded in a deep respect for patients as unique living beings and the 
obligation to care for them on their terms (Epstein & Street, 2011).   
With patient-centered care prominently situated on the political agenda, the Patient 
Protection and Affordable Care Act (ACA) was enacted in March 2010, bringing renewed 
emphasis to the concept. The passing of the ACA, with its many payment and delivery system 
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reform provisions, has brought about a host of changes to the way care is paid for and delivered. 
Today’s complex and ever-changing healthcare arena demands that organizations simultaneously 
strive to reduce costs, improve quality of care, enhance patient satisfaction, and advance the 
health of populations. Sadly, in many healthcare settings, the strategies designed to achieve these 
goals situate the patient as more of a recipient of healthcare services than an active partner with 
their healthcare providers and care team (Daniel, Deering & Murray, 2014). Organizations 
operating with this mindset would likely contend that a better managed healthcare organization 
leads to better outcomes. Consequently, these organizations often focus on more efficient 
processes and services. Nevertheless, patient-centered care is critical to improving health 
because a patient’s actions have a significant impact on health outcomes (Daniel et al., 2014). 
Accordingly, health systems that focus more on efficient processes and services, rather than on 
the patient, are unlikely to maximize health outcomes.  
The statistics associated with chronic illness provide tremendous incentive to shift the 
focus to patients and emphasize chronic management and preventative medicine. The Centers for 
Disease Control and Prevention (CDC) (2015) reports that chronic illness is the most common, 
costly and—perhaps most importantly— preventable of all health problems. In addition, as of 
2012, about half of all adults in the United States (117 million people) reported having at least 
one chronic illness while one in four reported having two or more (Ward, Schiller, & Goodman, 
2014). With chronic disease cited by the CDC (2015) as the cause of 7 out of 10 deaths each 
year, one could argue that the nation’s challenges are a result of a “health” rather than a 
“healthcare” crisis. 1 
A common thread in healthcare reform in the United States is the emphasis on effectively 
                                                
1 Health is defined as “a state of complete physical, mental, and social well-being and not merely the absence of disease or 
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managing the care of patients with chronic conditions (Rai, Prichard, Hodach, & Courtemanch, 
2011). However, an effective healthcare organization should not focus solely on chronic disease 
management, but on prevention and reduction as well. Recognizing that medical care is one of 
many determinants of health, healthcare organizations should strive to improve patient 
experiences across the spectrum. Under this model, the greatest gains in delivery can be achieved 
by addressing poor health as the underlying problem.  
Many of the important developments in policy and practice stemming from the ACA 
(e.g., accountable care organizations, patient-centered medical home) emphasize the patient as 
the key to accomplishing reform objectives and thus provide a framework for shifting to patient-
centered care (Daniel et al., 2014, para.1). These developments recognize that patients are not the 
object of care, but rather full-fledged participants in it; and unless participation is active and 
informed, the impact of healthcare is severely muted (Gruman, Jeffress, Edgman-Levitan, 
Simmons, & Kormos, 2011). Therefore, building and sustaining an affordable, high quality, 
patient-centered healthcare system requires a deep commitment to patient engagement as the 
primary factor contributing to an optimal state of health for patients.  
Patient Engagement 
Patient engagement, the topic of this study, is a strategic focal point for healthcare 
providers, administrators, policymakers, and payers. Predictably, in May 2015, 72% of 
healthcare leaders, surveyed at the Health Information and Management Systems Society 
(HIMSS) leadership conference, viewed patient engagement as one of the most important issues 
impacting their organizations (Noteboom, 2015). In July 2015, the American Hospital 
Association (AHA) reported that patient engagement was also a top priority for the nation’s 
hospitals based on the 2015 Most Wired survey (AHA, 2015). The literature reflects several 
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variations in the definition of the term “patient engagement”; however, in its simplest form, 
patient engagement refers to providers and patients working together to improve health (HIMSS, 
2015). The Agency for Healthcare Research and Quality (AHRQ), as quoted by Irizarry, Dabbs 
and Curran (2015), defined patient engagement as “the involvement in their own care by 
individuals (and others they designate to engage on their behalf), with the goal that they make 
competent, well-informed decisions about their health and healthcare and take action to support 
those decisions” (para.1).  
It is widely accepted that patients who are informed, activated, and engaged as active 
partners in their own care, with their physicians and care providers experience better health 
outcomes (Quevedo & Gold, 2010). Existing literature reveals a host of additional clinical, 
operational, and financial benefits resulting from greater patient engagement: increased patient 
satisfaction, increased staff retention, enhanced staff recruitment, reductions in the number of 
office visits, disease awareness, decreased length of stay, improved self-care, decreased ED 
return visits, fewer medication errors, reduced doctor shopping, and improved liability claims 
experience (Charmel & Frampton, 2008; Woods et al., 2013; Shimada et al., 2013; Neuner, 
Fedders, Caravella, Bradford & Schapira, 2015; Riippa, Linna, & Ronkko, 2014; Graffigna, 
Barello, Libreri, & Bosio, 2014). In view of these benefits, patient engagement is a crucial 
component to the multifaceted solution required to address the cost and quality crisis in US 
healthcare (Irizarry et al., 2015, para. 1).  
Patient engagement is deemed particularly valuable in the drive to improve health 
because it supports and promotes self-management. Self-management (SM) can be defined as 
“strategies a person undertakes to control disease, promote health, and live well with illness. 
Behaviors to manage disease include taking medication, seeking health-care, or managing pain” 
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(Audulv, 2013, p. 2). To distinguish between the two concepts, patient engagement focuses on 
strategies that providers use to recruit patients to manage their own health and promote positive 
health behaviors (James, 2013). In contrast, SM consists of a range of activities or tasks patients 
do to enhance their health and well-being (Boger et al., 2015).  
Past research, such as the randomized clinical trial conducted by Hibbard, Mahoney, 
Stock, and Tusler (2007) suggest that an increase in patient engagement is related to a positive 
change in a variety of SM behaviors (Hibbard et al., 2007). In multidisciplinary health research, 
engagement is often regarded as a determinant for patient empowerment and disease SM 
(Barello, Graffigna, Vegni, & Bosio, 2014). Patient engagement and SM thus work in tandem 
and are both essential elements to effective chronic disease improvement. For chronically ill 
patients who must manage their conditions on a daily basis, both patient engagement and SM is 
of utmost importance, and if patient engagement is increased, SM behaviors usually follow 
(Hibbard et al., 2007). 
Patient engagement and SM have become focal points of discussion because they 
represent fundamental principles for patient-centered healthcare (Pulvirenti, McMillan, & Lawn, 
2014). The focus is significant because “the more we can engage patients to be partners in their 
own care, the healthier they— and our entire healthcare system— will be” (Long, as quoted by 
McKinney, 2012, para.5). Greene and Hibbard (2012) added that surviving and thriving in the 
new payment environment would require health systems and providers to “identify effective 
ways to support patients so that they may be more effective partners in the care process” (p. 
524). Therefore, to ease the burden of growing demand and restricted resources, healthcare 
providers have begun developing and implementing practices to engage the most underutilized 
asset of healthcare—the patient—in the care process (Riippa, Linna & Ronkko, 2014).  
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The Role of Health IT in Patient Engagement 
Health Information Technology (HIT) is essential to the success of the ACA and has been 
identified as a vital tool for facilitating greater patient engagement. HIT is defined as “a broad 
concept that encompasses an array of technologies to store, share, and analyze health 
information” (HealthIT.gov, 2013). Steichen and Gregg (2015) indicated “HIT provides an 
opportunity to organize disparate data sources into one cohesive, patient-centered record” (para. 
2). The Office of the National Coordinator for Health Information Technology has offered the 
following proposed vision of how HIT can support a paradigm shift to patient-centered care: “the 
power of each individual is developed and unleashed to be active in managing their health and 
partnering in their healthcare, enabled by information and technology” (Daniel et al., 2014, p. 3). 
The role of HIT in patient engagement is significant because the on-demand, real-time 
communication preferences of today’s consumers would be virtually impossible without a sound 
HIT infrastructure.  
Electronic Health Record and Meaningful Use 
One example of HIT is the Electronic Health Record (EHR). The EHR is an electronic 
system maintained by providers (such as hospitals) that stores health information. Centers for 
Medicare and Medicaid Services (CMS) views EHR technology as “the next step in the 
continued progress of healthcare that can strengthen the relationship between patients and 
clinicians” (CMS, 2012). Accordingly, CMS strives to increase the adoption of EHRs by both 
physicians and hospitals through the use of the Medicare and Medicaid EHR incentive programs 
(CMS, 2014). These programs enable eligible physicians and hospitals to qualify for incentive 
payments to offset the costs of their systems (CMS, 2014). However, simply adopting an EHR 
system is insufficient. To realize the EHRs full potential, and to earn payments through the CMS 
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programs, eligible physicians and organizations must also demonstrate that they are using 
certified technology in a “meaningful” way (Wager, Lee, & Glaser, 2013, pp. 180-181).  
CMS also believes that the use of portal technology places healthcare providers in the 
best position to encourage patients to take a more active role in their care (HIMSS, 2014). 
Accordingly, to satisfy Stage 1 Meaningful Use requirements, providers must install a patient 
portal. Prerequisites for meeting Stage 2 go a step further and require at least one patient seen 
during the reporting period (or their authorized representatives) to use the portal to view, 
download, and/or transmit their health information to a third party (CMS, 2016). According to 
Irrizarry et al. (2015), the meaningful use criteria of the CMS EHR incentive program serves as 
the current principal driver of patient portal development. The features mandated by MU that are 
directly related to patient portal functionality include providing (1) a clinical summary to the 
patient after each visit, (2) secure messaging between provider and patient, (3) ability to view, 
download, and transmit personal health record data, (4) patient specific education, (5) patient 
reminders for preventative services, and (6) medication reconciliation (Ahern et al., 2011, as 
cited by Irizarry et al., 2015). Wright, Feblowitz, Samal, McCoy, and Sittig (2014) reported that 
237,267 eligible providers (EPs) registered for the Medicare EHR incentive program as of May 
30, 2013 and were paid a total of over $3 billion in incentive payments by CMS. 
Patient Portals 
Patient portals represent “important technological means to support patient-centered 
care” (Rigby et al., 2015, p. 150). Portals are web-based applications that are owned and 
administered by healthcare institutions and serve to enhance patient-provider communication; 
empower patients; support cares between visits; and most importantly, improve patient outcomes 
(Rigby et al., 2015). Since portals represent electronic entry points into the EHR, they contain 
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features intended to engage patients to be more active in managing and monitoring their health 
(Goel et al., 2011; Kruse, Argueta, Lopez, & Nair, 2015). While SM tools can differ in each 
portal, the majority includes features such as clinical summaries, patient-specific education 
resources, secure electronic messaging with providers, and reminders for preventative and follow 
up care (ONC, 2013). For patients charged with self-managing their chronic conditions, the 
portal can be a valuable resource. Prior to patient portals, patient-specific clinical information 
was typically dispersed in a collection of paper records—which are often poorly organized, 
illegible, and difficult to retrieve—making it nearly impossible to manage chronic conditions that 
require frequent monitoring and ongoing patient support (IOM, 2000, p.5). In the evolution of 
the shared-decision making model of care, the patient portal represents an innovative strategy for 
facilitating patient engagement and SM.  
For purposes of this study, it is important to distinguish the differences between patient 
portals and personal health records (PHRs). PHRs contain the same type of information as 
patient portals (e.g. immunizations, diagnoses, medications) but are owned, accessed, and 
managed by patients (ONC, 2015). Conversely, health information in a patient portal is largely 
created and managed by authorized providers, though some patient personalization is typically 
possible. Terry (2008), as cited by Nazi (2013), reiterated the key differences and benefits of a 
patient portal over a PHR, noting “a PHR that doesn’t connect to your doctor is like an ATM 
without any money in it” (p. 28). Related to patient engagement, the differences in ownership 
and management between the patient portal and PHR are significant, since the latter is only 
updated when the patient updates it (Kruse, Bolton, & Freriks, 2015; Kruse, Argueta, et al., 
2015).  
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Self-Management using the Patient Portal  
Self-management (SM) is considered crucial in chronic disease management. Since 
health behaviors (such as smoking, food choices, and alcohol use) are linked to the majority of 
chronic health problems, use of patient portals in this growing population is important. Fittingly, 
Kruse, Arugeta, et al. (2015) indicated that patients who used patient portals showed significant 
improvements in the SM of their chronic disease. 
One large academic medical center in the southeastern United States implemented a new 
integrated EHR system, Epic®, on July 1, 2014. Within Epic is a comprehensive patient web-
portal called MyChart® that allows patients to engage in their care (e.g. examine test results, 
view upcoming and past appointments, and update medications and allergies). One helpful 
feature within MyChart® is the ability to view, modify, and cancel upcoming appointments. 
Once appointments are scheduled, MyChart® sends an email to patients, reminding them of 
upcoming visits. This feature has the potential to minimize missed appointments, because 
patients who are engaged in the SM of their conditions were shown to participate in preventative 
behavior, which includes adherence to medical appointments (Riippa, Linna, & Ronkko, 2014). 
Conversely, absent a personal or family emergency, missing appointments suggests poor SM, 
likely a misunderstanding of the value of the appointment or “forgetting.” In a chronically ill 
population, missed appointments represent a key obstacle in the quest to improve health.  
A missed appointment occurs when a patient cancels within 24 hours of the scheduled 
appointment time (“same-day cancellation”) or fails to show up (“no-show”). Same-day 
cancellations and no-shows can be detrimental on several levels. First, they pose major issues for 
both physicians and healthcare organizations; quality of care is substantially compromised, 
already scarce financial resources are further drained, and productivity is dampened. Second, and 
 18 
more importantly, no-shows and same-day cancellations pose major issues for patients 
themselves. Patient wait time is increased, and patients with chronic illnesses, such as diabetes, 
have more difficulty receiving regular care and follow up. More than most chronic diseases, 
diabetes requires a deep commitment to self-care because patients with diabetes are responsible 
for the vast majority of management requirements of their condition (McMahon et al., 2005). 
Diabetes 
Osborn, Mayberry, Wallston, Johnson, and Elasy (2013) indicated that optimal diabetes 
SM is multifaceted, requiring activities such as exercise, appropriate nutrition, blood glucose 
monitoring, and medication adherence (para.1). However, the complex nature of SM activities 
often necessitates frequent support and oversight from a team of medical professionals. National 
clinical practice guidelines recommend patients visit their primary care provider (PCP) every 3 
to 6 months (Nuti et al., 2012). 
When patients with diabetes miss appointments or when they cannot get timely 
appointments because the schedule is filled with patients who will no-show, health outcomes 
deteriorate (Turkcan et al., 2013). Poorer glycemic control, reduced metabolic control, sub-
optimal SM practices, and significantly higher rates of subsequent acute care utilization are all 
associated with diabetic patients who miss scheduled appointments (Karter et. al, 2004; Nuti et 
al., 2012; Schectman, Schorling, & Voss, 2008). In addition, Nguyen, DeJesus, and Wieland 
(2011) found that when patients frequently missed appointments, they were less likely to receive 
necessary preventative health services, which led to poorly controlled hypertension and diabetes.  
Therefore, “a vital role of the healthcare system is to provide the tools necessary for 
chronically ill patients to make informed decisions about their healthcare, and to solve the 
problems encountered daily from living with a chronic condition” (Solomon, Wagner, & Goes, 
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2012, para. 1). The patient portal is one such tool, and may represent a powerful instrument for 
engaging patients in the SM of their condition (Nijland, van Gemert-Pijnen, Kelders, 
Brandenburg, & Seydel, 2011). Solomon et al. (2012) agreed that web-based interventions could 
serve a vital role in healthcare providers’ efforts to enhance SM in this growing population of 
chronically ill people. Portal technology has therefore become a priority for many healthcare 
organizations worldwide. By leveraging interventions that facilitate patient scheduling, improve 
attendance to provider appointments, and provide patient information to care teams, healthcare 
providers enable preventative services to begin (Nuti et al., 2015). Accordingly, the patient portal 
can potentially be a crucial first step in facilitating adherence to the American Diabetes 
Association (ADA) effective disease management guidelines because they engage patients by 
keeping them accountable for their health, making them more likely to schedule and attend their 
provider appointments (Nuti et al., 2015).  
Problem Statement 
Patient portals are recognized in the literature as a promising mechanism to encourage 
greater patient engagement and resulting SM (Irizarry et al., 2015). In spite of the great promise 
that portals have shown for helping manage, maintain, and improve patient health, their 
association with patient outcomes, utilization, and cost is unclear. Further, the impact of 
electronic patient portals on safety, effectiveness, quality of care, and patient engagement is 
limited and inconclusive (Rigby et al., 2015). Finally, while they are touted as a transformative 
technology for facilitating disease SM and patient-centered healthcare, little is known about the 
impact of portals on diabetes care and associated outcomes specifically (Osborn et al., 2013).  
The literature suggests that web-based multidisciplinary tools—such as patient portals, 
that enable patients to schedule appointments or remind them of the date and time of an 
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appointment—can have a positive impact on clinical and behavioral outcomes (Nuti et al., 2015). 
Unfortunately, little research exists for the outcome parameters of no-shows and same-day 
cancellations in a chronically ill population, such as patients with diabetes. Horvath et al. (2011) 
documented the use of the patient portal to improve patient adherence, specifically reduce missed 
appointments. This study focused on the association between portal enrollment, with email 
reminders, on clinic adherence. The conclusion was that patients who registered for portal use 
had a significantly reduced no-show rate, thus the patient portal “may have important beneficial 
effects on clinic operations” (Horvath et al., 2011, p. 17). While useful, the Horvath et al. (2011) 
study had several limitations. Since it only studied portal enrollment, it might not reflect the 
activity of active portal enrollees, as patients who sign up for the portal do not necessarily use it. 
The study also lacked detailed information regarding the number of log-ins of active enrollees. 
As the authors noted, this information would have made a stronger case that active portal use is 
an important component of patient arrivals. Further, data on advance cancellations (same-day or 
otherwise) were not captured (Horvath et al., 2011). 
The present study aims to improve upon prior research by addressing the aforementioned 
limitations. Specifically, the study will focus on: 
1. Better understanding a chronically ill population of adult diabetics who may gain 
significant benefit from greater patient engagement and resulting SM;  
2. Exploring who currently uses the portal in an adult diabetic population, as this 
information represents an important first step for increasing future use; and 
3. Determining the relationship between the actual use (not merely enrollment) of 
the patient portal and missed appointments. 
Adequately describing and assessing the use of the portal in facilitating patient 
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engagement and SM is necessary to determine how to better utilize this technology to improve 
health outcomes. This descriptive study will contribute to that necessary foundation.  
Study Objectives 
The objective of this study is to describe the demographic characteristics of patients with 
diabetes who use the MyChart® patient portal at a large academic medical center. Jones, Weiner, 
Shah, and Stewart (2015) stated that by determining which patient characteristics predict use of 
patient portals, organizations can develop targeted approaches to engage different segments of 
the population. This study contributes to previous research (especially Riippa, Linna, Ronkko, et 
al., 2014) by extracting predictors of portal use in a chronically ill population who would benefit 
considerably from appointment adherence. Most importantly, this study will demonstrate the 
relationship between portal use and missed appointments (i.e., no-shows and same-day 
cancellations) and identify whether portal use is associated with fewer missed appointments. 
Research Questions 
1. What are the demographic profiles of MyChart® users?  
2. What demographic characteristics predict MyChart® use? 
3. Does MyChart® use predict overall no-show percentage? 
4. Is there a difference in patients’ missed appointment percentage when they have 
an activated MyChart® account compared to when they do not?  
Research Hypotheses 
It is hypothesized that no-show rates are associated with MyChart® use among diabetic 
patients. Further, it is hypothesized that when patients activate a portal account before an 
appointment, and therefore receive email reminders of their upcoming visit, their missed 




This study included all adult patients (age 18-80) with a Diabetes Mellitus (DM) 
diagnosis who had a primary care provider (PCP) within the Medical University of South 
Carolina (MUSC) network and were seen for an appointment between 7/1/14-6/30/15. The 
Diabetes Registry was used to identify patients in the study population. Patients with diabetes 
that had a pregnancy due date anytime in the future were excluded to avoid the inclusion of those 



















A search of published, peer-reviewed literature was conducted between September 2015 
and November 2015 for articles that analyzed the use of patient portals to engage patients. The 
PubMed, CINAHL, and Scopus research databases were queried for both qualitative and 
quantitative studies published in the English language between 2010-2015. The search strategy 
included combinations of the following terms: missed (or missing or fail) appointment, electronic 
health record, EHR, electronic medical record,  patient portal, mobile app, smart phone, self-
manage, self-management, diabetes, appointments & schedules, computerized patient record, 
and patient participation. In addition, although previously indexed in each of the research 
databases, a key journal search was performed in the Journal of Medical Internet Research, 
because the periodical is deemed a high-volume publisher of innovative research in the 
informatics field. Official governmental websites (e.g. CMS, HealthIT.gov) were also reviewed 
for regulatory guidance. A MUSC librarian was consulted for assistance in selecting the 
databases and search terms to retrieve potential articles.  
Scopus searches consisted of the title, abstract, and keyword fields; the CINAHL 
searches included headings and keywords; and the PubMed search utilized title, abstract, 
keywords, and MESH headings. Additional references were obtained by citation review in key 
articles. Filters were applied to exclude articles outside of the desired date range (2010-2015) as 
well as those that were not in the English language. The date range was selected because the 
enactment of the HITECH Act occurred in February 2009, placing new requirements, such as 
patient portal usage, on healthcare organizations striving to meet meaningful use criteria. In 
addition, with the current focus on patient-centered care, this topic is updated routinely. A filter 
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was also used to exclude the MEDLINE results from the CINAHL search, as PubMed 
automatically queries MEDLINE.  
Many articles returned in the initial search discussed personal health records (PHRs). 
This study’s focus is on patient engagement through the patient portals; therefore, only studies 
that specifically referenced patient portals were included. The exclusion process was manual, 
conducted by one reviewer, and involved a critical review of the title and abstract of each article. 
Articles were then discarded or selected based on their relevance to the current study.  
Theoretical Framework  
The theoretical framework utilized for this research was Ryan and Sawin’s (2009) 
Individual and Family Self-Management Theory (IFSMT). The IFSMT is a descriptive theory 
that conceptualizes SM as a multidimensional, complex phenomenon that affects individuals, 
dyads, or families across all developmental stages (Ryan & Sawin, 2009, p. 222). 
The IFSMT (see Figure 1) and the conceptual model adapted from it to fit this study, 
serve as the foundation for this literature review.  
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Figure 1: IFSMT Theory 
The IFSMT was selected because of its emphasis on the responsibility of chronically ill 
individuals and their families to actively manage their conditions. This theory focuses on the risk 
and protective factors (defined in this study as barriers and facilitators) leading to the 




Factors in the context dimension consist of risk and protective influences that are 
categorized as condition-specific considerations, physical and social environments, and 
individual and family characteristics. The condition-specific characteristics associated with 
diabetes are the multiple comorbidities that often accompany the illness as well as the required 
routine follow-up and daily SM requirements. Environmental factors are either physical or social 
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and include factors such as transportation, access to healthcare, and transition from one 
healthcare provider or setting to another. Individual and family factors are associated directly 
with the individual or family (e.g. literacy) (Ryan & Sawin, 2009). The factors in the context 
dimension either enhance or present barriers to SM and affect an individual’s and family’s ability 
to engage in the next two dimensions: process and outcomes (Ryan & Sawin, 2009).  
The process dimension is based on the dynamic interaction among the following: 
knowledge and beliefs, acquisition and use of self-regulation skills, and social facilitation and 
negotiation (Ryan & Sawin, 2009). That is, persons will be more likely to engage in SM 
behaviors if they have information about and embrace knowledge and beliefs consistent with 
behavior, if they develop the ability to change their behavior, and if they experience social 
facilitation (e.g. support) that encourages them to engage in preventative health behaviors. In this 
study, the process dimension is represented by the MyChart® patient portal. The portal is a tool 
that may enhance an individual and their families’ SM processes and may therefore result in 
positive improvements in the next dimension: outcomes (Ryan & Sawin, 2009).  
The outcome dimension includes proximal (i.e. short term) outcomes that lead to the 
attainment of distal (i.e. long term) outcomes. Proximal outcomes consist of the actual 
engagement in SM behaviors such as treatment regimens and the use of pharmacological 
therapies that are specific to a condition, risk, or transition (e.g. diabetics must perform daily 
finger sticks to measure their blood glucose levels). The proximal outcomes in this study are no-
show and same-day cancellation rates. Distal outcomes such as improved health, improved 
quality of life, and improvements in both direct and indirect costs are related, in part, to the 
successful achievement of proximal outcomes (Ryan & Sawin, 2009).  
In the past five years, the IFSMT model has been used in other studies to explain a 
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variety of research topics. A correlational, longitudinal design framed by the IFSMT was used to 
determine the relationship between patient perceptions of patient-empowering nurse behaviors 
and patient activation and functional health status six-weeks after discharge in patients who 
recently underwent a surgical procedure (Jerofke, 2013). Derman (2014) used the IFSMT to 
examine themes discussed by United States veterans and their significant others who used secure 
messaging to include the patterns of use and whether the patterns varied based on gender and age 
of the user. Verchota (2014) conducted a correlational, cross-sectional study to determine 
whether SM behavior in adolescents with type 1 diabetes mediated the relationship of IFSMT 
process variables on metabolic control and diabetes-specific health-related quality of life 
(DQOL). Most recently, Colorafi (2015) used the IFSMT to examine ways of encouraging older 
adults with multiple co-morbidities to engage with their plan of care. The current study will 
contribute to the body of knowledge surrounding this understudied mid-range theory by using it 
to examine another dimension of patient engagement. That is, patient engagement and SM 
through the patient portal in a population of adults with diabetes.  
For purposes of this research, the IFSMT has been modified to focus on sensitizing 
concepts most relevant to this study. Sensitizing concepts offer ways of seeing, organizing, and 
understanding the literature and provide starting points for building analysis (Charmaz, 2003, as 
cited in Bowen, 2006). Sensitizing concepts are thus utilized as points of departure from the 
original theoretical framework and provide proper context for studying the engagement and SM 
of a diabetic population through a patient portal.  
Review of the Literature 
The potential for patient portals to improve patient engagement and health outcomes has 
been discussed for well over a decade. Historically, authors have tried to illuminate the subject 
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by highlighting the great potential patient portals show for engaging patients (Byczkowski, 
Munafo, & Britto, 2014; Solomon et al., 2012). Given the number of office visits, laboratory and 
procedure visits, and SM activities chronic illnesses necessitate, patient portals may be an 
especially useful tool for this patient population (Ancker et al., 2011; Byczkowski et al., 2014; 
Krist et al., 2014; Riippa, Linna, Ronkko, et al., 2014). Accordingly, condition-specific factors 
(e.g. complexity of condition and treatment) are likely to encourage portal adoption and use.  
Several studies describe the value of the portal from the patient’s perspective. The 
findings suggest that patients find portals easy to use, useful for communicating with their care 
provider, facilitative of participation in their own care, and therefore having great value and 
utility (Nagykaldi, Aspy, Chou, & Mold, 2012; Urowitz et al., 2012; Woods et al., 2013).  
Recent publications reveal that in spite of the portal’s great promise, and in spite of any 
external incentives, both patients and providers have adopted patient portals at slow rates in the 
United States, demonstrating that adoption and use is complex (Tulu et al., 2015). Articles 
summarized and synthesized in this literature review were selected based on their relevance to 
IFSMT conceptual dimensions. Accordingly, they address characteristics associated with portal 
enrollment and use in a diabetic population, as well as examine barriers to use that future studies 
should address.  
Portal Adoption and Use. The literature cites a host of reasons for poor adoption and 
use of patient portals, and distinguishes among patient populations who are faced with different 
challenges. Several studies have concluded that there are significant demographic differences 
between portal users and nonusers. The most common factors discussed include health literacy, 
race/ethnicity, educational attainment, and age. These disparities among subgroups are often 
defined as the “digital divide” and represent major barriers to patient portal access (Irizarry et al., 
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2015). The majority of published studies about patient portals have been conducted in the 
general population instead of in a population restricted to patients with diabetes (Ronda, 
Dijkhorst-Oei, Gorter, Beulens, & Rutten, 2013, p. 556). However, given the complex SM 
demands on diabetics, the studies synopsized in this section of the literature review are limited to 
those relevant to SM and/or use of the patient portal in diabetic populations.  
White, Wolff, Cavanaugh, & Rothman (2010) explained that patients with diabetes and 
limited health literacy (LHL) are more likely to have poorer disease knowledge and symptom 
recognition, poorer glycemic control, greater difficulty interpreting food labels and estimating 
portion sizes, lower self-confidence in diabetes management, fewer SM behaviors, and poorer 
communication with their providers (p. 1). LHL is especially prevalent in certain racial or ethnic 
groups, the elderly, and people with little education (AHRQ, 2004, as cited in McCleary-Jones, 
2011). Therefore, it comes as no surprise that LHL, race/ethnicity, and educational attainment, 
represent strong predictors of portal enrollment and use.  
Limited Health Literacy. LHL is consistently associated with poor SM behaviors and 
unfavorable health outcomes in people with diabetes, which has led to a growing body of 
literature that explores this relationship (Al Sayeh, Majumdar, Williams, Robertson, & Johnson, 
2013; Mayberry, Rothman, & Osborn, 2014; van der Heide et al., 2014).  
Al Sayeh et al. (2013) evaluated the relationships between health literacy (HL) and 
clinical outcomes (glycemic control, hypoglycemia, blood pressure, diabetes complications, and 
low-density lipoprotein (LDL)), behavioral indicators and patient-reported outcomes (diabetes 
knowledge, self-efficacy, self-care, self-monitoring of blood glucose and other SM), and health 
literacy and patient-provider interaction indicators (patient-provider communication, patient 
trust, information exchange and involvement in decision-making, use of computers and the 
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Internet, and other outcomes (e.g. Health-Related Quality of Life [HQRL]). They found that 
while there was a discrepancy among studies regarding the relationship between HL and several 
health outcomes in people with diabetes, there was sufficient evidence to support a positive 
relationship between HL and SM activities and HL and diabetes knowledge (Al Sayah et al., 
2013).  
Relatedly, van der Heide et al. (2014) found that LHL was significantly associated with 
reduced diabetes knowledge, higher HbA1c level, less self-control of glucose level, and less 
physical activity. This study supported and enhanced the previous findings from Al Sayeh et al. 
(2013) by demonstrating that higher HL may contribute to participation in SM activities, in some 
cases through diabetes knowledge. Thus, health literacy skills may be important targets for 
interventions promoting diabetes SM (van der Heide, et al., 2014).  
Since diabetes SM occurs in the context of routine family activities, Mayberry et al. 
(2014) included family members as an essential source of support for SM among adults with 
Type 2 Diabetes Mellitus (T2DM). They therefore studied how social or family support may 
affect diabetes outcomes differently for adults with LHL versus those with adequate HL. They 
found that being non-white or Hispanic was associated with having LHL, as was having less 
education or a lower income. Their results suggest that adults with LHL are especially vulnerable 
to the harmful aspects of family involvement in their diabetes management (e.g., nagging or 
arguing with patients in an attempt to get them to perform SM behaviors, or tempting them with 
unhealthy foods). The Mayberry et al. (2014) study shows that efforts focused on increasing 
social support or family support for diabetes SM may not be effective unless they also decrease 
obstructive family behaviors, and this appears especially relevant to patients with LHL. The 
impact of family members’ involvement should also be evaluated as a means to increase portal 
 31 
use, especially among those with LHL (Mayberry et al., 2014).  
Several authors described LHL as a key characteristic associated with non-use of the 
patient portal. For example, Mayberry, Kripalani, Rothman, and Osborn (2011) found a 
relationship between patients’ HL and the frequency of using computers to research diabetes-
specific medications or treatments. However, contrary to the authors’ predictions, participants 
with LHL, numeracy, or computer literacy were no less likely to access patient web portals. 
Therefore, HL was associated with the frequency of using the portal to manage one’s health but 
was not necessarily a prerequisite to accessing the portal. To better understand the finding, 
Mayberry et al. (2011) reviewed focus group transcripts to determine how participants used the 
patient portal regardless of their HL, numeracy, or computer literacy. In that study, family 
members facilitated both initial access and continued use of the portal and participants 
commonly learned about the medical center’s patient portal through a knowledgeable family 
member. Accordingly, the involvement of family members in patient care might assist patients 
with HL limitations in accessing and using patient portals to manage their diabetes, bridging the 
HIT “digital divide” (Mayberry et al., 2011).  
Zikmund-Fisher, Exe, and Witteman (2014) added that LHL and numeracy skills were 
significant barriers to basic use of laboratory test results found in most portals. Those with LHL 
and low numeracy skills were less than half as likely to identify hemoglobin A1C levels as out-
of-range as patients with adequate HL. This finding was important because “correctly identifying 
hemoglobin A1C levels as out of range was the single largest predictor of both perception of 
blood glucose control and intention to call one’s doctor in response to the elevated test results” 
(Zikmund-Fisher et al., 2014, p. 13).  
Zarcadoolas, Vaughon, Czaja, Levy, and Rockoff (2013) argued that vulnerable 
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population groups are often subject to disparities in health outcomes and healthcare quality. 
Many of these vulnerable populations (e.g., poor, undereducated, racial and ethnic minorities, 
immigrants, and those lacking English proficiency) are also likely to be low literate and/or LHL, 
with some reading at a 5th grade level or lower. Unfortunately, the literacy level of most health 
information created for the general public is written at or above the 10th grade level, which 
complicates or hampers the effectiveness of the SM or patient-centered approach. Studies have 
suggested that providing access to online health information through the patient portal may help 
to address some of the disparities in vulnerable groups. However, there is conflicting data 
regarding vulnerable patients’ perceptions and the use of patient portals. Therefore, Zarcadoolas 
et al. (2013) sought to identify vulnerable patients’ responses to patient portals, how they 
perceived the portals utility and value, as well as their reactions to specific portal functions. Most 
focus group participants felt the portal’s reminders for appointments, annual visits, and 
screenings positively impacted their health. However, participants discussed the need to have 
portal information presented in ways “the average person can understand” (p. 12). After being 
shown a sample lab test result page, one participant commented that she would use it “if I could 
read it and understand it…[but] I can’t understand it” while another participant stated, “I just 
look and see numbers” (p. 18).  
Each of the referenced studies reiterates the importance of designing and refining patient 
portals to meet the needs of those with LHL (Zarcadoolas et al., 2013). Otherwise, “patient 
portals will remain an unused or underutilized tool for those who could potentially benefit the 
most” (p. 14).  
Race/Ethnicity and Educational Attainment. In addition to concerns over HL, a number 
of studies describe race/ethnicity as a strong predictor of portal enrollment and use (Amante, 
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Hogan, Pagoto, & English, 2014; Ancker et al., 2011; Goel et al., 2011; Osborn et al., 2013; 
Sarkar et al., 2011; Tenforde, Nowacki, Jain & Hickner, 2012). Unfortunately, previous health 
services research has also revealed social disparities in diabetes outcomes by race/ethnicity and 
education (Wilder 2003, as reported by Sarkar et al., 2011). As more health systems adopt portal 
functionality, minority patients are in danger of falling further behind if the disparities in 
adoption and use described below are not adequately addressed (Sarkar et al., 2011).  
Sarkar et al. (2011) investigated use of a patient portal among 14,102 diverse adults with 
diabetes. Study findings revealed marked race/ethnic differences with African-Americans, 
Latino, and Filipino patients least likely and Asian and White participants most likely to both 
request a password and log on to the portal. They also observed a consistent gradient with 
respect to educational attainment, such that those with higher educational attainment were more 
likely to request a password and log on to the portal. Compared to those with a college degree, 
those with a lower educational attainment were more likely never to have logged on (Sarkar et 
al., 2011).  
Ancker et al. (2011) concurred that activation was significantly more likely among older 
patients, non-Blacks, speakers of English or other languages compared to Spanish speakers, the 
privately insured, and those with more clinical visits. Repeat use was significantly more likely 
among Whites, English speakers, those with commercial insurance or Medicaid, and those with 
more chronic illnesses. Therefore, according to Ancker et al. (2011), racial and economic 
disparities are evident at all stages of access to the portal, activation of portal accounts, and usage 
of accounts.  
Tenforde et al. (2012) found that compared to nonusers, users were younger, had higher 
incomes and educational attainment, were more likely to identify as Caucasian, and had better 
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unadjusted and adjusted diabetes quality measure profiles. Of the 4,036 patients who enrolled in 
the portal, the median number of login days during the 12-month study period was nine. This 
study suggested that patients are logging on too infrequently for portals to be as effective as 
hoped in improving outcomes in this subset of the population. Portals need to engage patients 
with diabetes on a more regular basis and provide tailored, action-oriented advice to improve 
their SM (Tenforde et al., 2012).  
Osborn et al. (2013) conducted a mixed-methods study to understand who used the 
patient portal and discover reasons for nonuse; how portal users utilized the portal to manage 
their medications; and participants’ ideas for improving portal functionality for medication 
management and adherence support. Users were more likely than nonusers to be 
Caucasian/White, have higher incomes, be privately insured, and be more educated than 
nonusers. After showing nonusers a portal demonstration video, four out of seven nonusers 
reported they were interested in using the portal but had either never heard about it, or had heard 
about it but did not know what its capabilities were. Among users, more frequent use of a portal 
was associated with better Hemoglobin AIC. This study was limited by the participants’ 
perceptions of the frequency of using a portal and how they use it, therefore, it may not 
adequately reflect actual opinions and/or behaviors (Osborn et al., 2013).  
Amante, et al. (2014) found that demographic factors such as higher education level, 
younger age, higher income, and non-minority race were associated with higher portal 
utilization. The authors suggest that educating patients, family members, and providers on how 
best to use portals and on the benefits of portal use can increase enrollment and use (Amante et 
al., 2014).   
Ronda et al. (2013) found that patients with T1DM requested a login more frequently 
 35 
than patients with T2DM. In addition, patients with a login were strikingly differently from those 
without. Namely, having a login was independently associated with younger age, male gender, 
higher educational level, treatment by an internist, longer duration of diabetes, and more frequent 
use of insulin and other drugs. This study concluded that promoting the patient portal without 
addressing disparities in use was an exercise in futility (Ronda et al., 2013). 
Nijland et al. (2011) evaluated patient portal user profiles and explored factors 
influencing the initial and long-term use of a Web-based application (DiabetesCoach) for 
supporting the self-care of patients with T2DM. Patients that enrolled to use the portal were 
mostly male, with a high or medium level of education, and a mean age of 61. This study was 
important because expanding the uptake of portal technology requires, first and foremost, a 
better understanding of the obstacles that prevent access (initial use) and secondly, a better 
understanding of the factors that influence long-term use (Nijland et al., 2011). Unfortunately, 
the study was limited by the incredibly small and select sample of participants (only 14% of 
patients invited to use the portal responded favorably). In addition, this study’s setting was a 
primary healthcare foundation in the Netherlands, which is considerably different from primary 
care practices in the U.S. (Nijland et al., 2011).  
By increasing convenience and access to medical record information and tools online, 
portals can lower barriers to engaging in SM tasks and may therefore reduce health disparities 
related to race/ethnicity and LHL as previously discussed (Lyles, Schillinger, & Sarkar, 2015). 
Lowering barriers to engagement in SM tasks can be particularly important for patients with 
chronic illness because they need increased assistance with complex SM activities. 
Unfortunately, Lyles, Schillinger et al. (2015) believe that “portal expansion is not fully realizing 
this promise” (p. 2). Lyles, Schillinger et al. (2015) argue that unfortunately “portal expansion is 
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not fully realizing this promise” and it is not an issue of access or interest alone (p. 2). With most 
Americans having internet access and the vast majority having interest in internet-based 
communication with providers, a lack of usability, particularly for diverse groups, was described 
as an additional formidable barrier to achieving widespread use of the portal (p. 3). Goel et al. 
(2011) added to this conclusion, that 26% of all respondents they interviewed in a telephone 
survey in one urban general medicine clinic did not remember even discussing the patient portal 
with their provider. Meanwhile, approximately 63% did not attempt enrollment despite 
remembering a discussion with their providers and cited issues such as not having enrollment 
instructions, not thinking it would be useful, thinking it would be too complicated, and lack of 
computer skills (Goel et al., 2011). They concluded that interventions aimed at reducing racial 
and ethnical disparities in enrollment should also address attitudinal barriers and not focus 
exclusively on access (Goel et al., 2011). 
Summary 
These studies reiterate the most common factors related to portal adoption and use in a 
diabetic population and suggest that LHL, race/ethnicity, and lower educational attainment all 
contribute to the problem of underutilization. Unfortunately, the important determinants of 
patient portal use described in this section are also directly related to the disproportionate burden 
of chronic illness and disparities in health outcomes (Lyles & Sarkar, 2015, p. 271). Therefore, 
promoting patient engagement through patient portals is challenging and rapid expansion of 
portals could exacerbate existing healthcare disparities if only well-resourced individuals use 
them (Lyles & Sarkar, 2015, p. 271).  
Conversely, with so many hospitals and clinics now using electronic health records and 
patient portals, well-designed technology may make a meaningful population impact (Lyles & 
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Sarkar, 2015). Tung and Peek (2015) agreed that the pervasive use of technology to address a 
disease such as diabetes, which is impacted by basic patient decisions from grocery shopping to 
stress management, provides a novel opportunity for facilitating the shift to patient-centered care. 
However, finding ways to overcome barriers posed by race/ethnicity, LHL, and lesser 
educational achievement should be an important policy goal to prevent these groups from falling 
further behind (Goldzweig et al., 2013; Sarkar et al., 2011).  
Barriers to Use 
Many of the contextual differences (factors that challenge or protect engagement in SM) 
in the uptake and use of portals are described above. However, after adjusting for socioeconomic 
status or Internet use in everyday life, differences in portal use persist, suggesting the influence 
of additional patient and/or provider and system-level factors (Lyles et al., 2013). Zarcadoolas et 
al. (2013) described that once a patient was enrolled in the patient portal, there were no 
disparities in use by race/ethnicity, indicating that the way portals are designed and presented to 
consumers may influence how they are perceived, valued, and ultimately utilized.   
The current major legislative and political support for EHRs represents the greatest 
investment in health information technologies in US history (Menachemi & Collum, 2011). 
These investments (e.g. EHR Meaningful Use incentive programs) have undoubtedly provided a 
tremendous platform for portal development and adoption. However, despite the large amount of 
stimulus money available, virtually all healthcare systems are still struggling with patient portal 
use, and the MU program has had to grant extensions for systems to meet patient engagement 
goals (Lyles, Schillinger et al., 2015, p. 2). These challenges underscore the fact that significant 
barriers still exist for both portal enrollment and use. This section will address one of those key 
barriers, insufficient evidence that the portal actually improves outcomes.  
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Evidence of Improved Proximal and Distal Outcomes  
HIT is a rapidly emerging field. Accordingly, an increasing number of studies have been 
published as of late that evaluates portals’ ability to improve outcomes. Some authors described 
the portal’s capacity to empower patients and improve disease awareness, which led to favorable 
patient-provider communication (Varsi, Gammon, Wibe, & Ruland, 2013; Wade-Vuturo, 
Mayberry, & Osborn, 2013; Woods et al., 2013). Other authors linked the patient portal to 
improvements in medication adherence and the management of chronic disease, decreases in the 
number of office visits, enhanced self-care, increased patient satisfaction, improved quality of 
care, and superior customer retention (Kruse, Bolton et al., 2015; Lyles, Sarkar et al., 2015; Varsi 
et al., 2013, p.2).  
Further, a variety of studies have identified clinically relevant benefits associated with 
use of patient portals. Many found that the portal was significantly associated with improved 
glycemic control and patients with both T1DM and T2DM who accessed a portal were more 
likely to achieve target A1c levels compared to patients who did not access a portal (Lau, 
Campbell, Tang, Thompson & Elliott, 2014; Wade-Vuturo et al., 2013).  
Related to the present study explicitly, Krist et al. (2012) argued that information systems 
that feature patient-centered functionality have the potential to increase preventive service 
delivery and thus provide important public health benefits (p. 318). Or and Tao (2014) added that 
the use of portal technology can lead to greater SM, higher frequency of attending health checks, 
greater physician activity levels, improved diet and eating behaviors, improved medication 
adjustment, and improved diabetes knowledge (p. 324).  
While there are many studies pointing to either real or potential benefits of patient 
portals, unfortunately there is currently insufficient evidence that the portal or its features 
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actually improves health outcomes (Kruse, Bolton, & Freriks. 2015). Therefore, even though the 
portal has great potential to meet the intents of MU, there is not enough evidence to declare its 
efficacy.  
 Solomon et al. (2012) concurred that even though the portal has great potential as a 
transformative technology in the management of chronic disease, evidence is needed that 
interventions like portals can produce benefits for a sustained period among a diverse population. 
Solomon et al. (2012) suggested that clarifying the value of web-based SM tools will stimulate 
the investments necessary to accelerate adoption throughout all segments of the large and 
growing chronic disease population. One important advancement needed is greater provider 
endorsement; many authors have described this practice as a significant barrier/facilitator to 
portal adoption and use because, for most patients, healthcare providers are likely to be the ones 
to introduce them to the portal and interest them in using it as a tool to help manage their health 
(Ancker et al., 2011). If providers are not familiar with the portal and its potential benefits, or are 
not convinced of its potential benefits, they are less likely to endorse the portal to patients’ 
posing a significant barrier to adoption and use (Amante et al., 2014; Ronda et al., 2013). Ryan 
and Sawin (2009) posit provider endorsement as social facilitation that includes social influence. 
Social influence is a message or dialogue in which respected persons with expert knowledge in 
positions of perceived authority with expert knowledge advise and encourage individuals and 
families to engage in specific health behaviors (Ryan & Sawin, 2009).  
Patients with T1DM and T2DM studied by Ronda, Dijkhorst-Oei, and Rutten (2014) 
indicated that they discovered the portals’ availability because their healthcare provider told 
them about it and lack of awareness was the main barrier to enrollment and use. When Ronda, 
Dijkhorst-Oei, and Rutten (2015) compared patients who requested a login but never used it or 
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once (“early quitters”) with patients who used it at least two times (“persistent users”) they again 
found that the majority of patients from both groups discovered the existence of the patient portal 
after being informed by their physicians. This finding reiterates the important role that the 
healthcare provider has in turning a patient into an active and persistent user (Ronda et al., 2015). 
Therefore, to increase patients’ participation in a portal, the unawareness of its existence and its 
possibilities need to be addressed by their healthcare professionals (Ronda et al., 2014).   
With provider endorsement established as a key barrier to portal adoption and use, 
Irizarry et al. (2015) argued that the perceived usefulness of the portal from the providers’ 
perspectives cannot be underestimated. Provider endorsement is one of the most influential 
factors impacting patients’ initial adoption as well as its continued use as a tool for collaborative 
communication (Irizarry et al., 2015). Therefore, one effective way to enhance provider 
endorsement may be to change provider behavior (including attitudes and beliefs) related to the 
portal (Ancker et al., 2011). Recognizing that many negative attitudes and beliefs may be related 
to a lack of provider confidence in the portals benefits, additional evidence of the portals’ 
potential to improve proximal and distal outcomes will be needed. Provider endorsement is 
critical from a systemic standpoint because the workflow of individual providers and the 
healthcare team as a whole (including nurses, pharmacists, support staff, and physicians) must be 
adapted to incorporate patient portal functionality, and the patient engagement it allows, to 
render effective illness management processes (Irizarry et al., 2015). Evidence that the portal 
actually improves outcomes for patients will help mitigate some of the barriers providers have 
identified as leading to their dissatisfaction. These barriers include lack of usability and 
interoperability, onerous regulatory requirements, decreased interaction with the patient, 
disruption of day-to-day workflow, and reduced quality of clinical documentation (Buntin, 
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Burke, Hoaglin, & Blumenthal, 2011; Lyles & Sarkar, 2015; Mangalmurti, Murtagh, & Mello, 
2010; Porter, 2014; Reece, 2011; Sinno, Gandhi, & Gamble, 2011; Sitting & Singh, 2012; 
Sockolow, Bowles, Lehmann, Abbott, & Weiner, 2012; Urowitz et al., 2012; Wylie, Baier, & 
Gardner, 2014). Goldzweig et al. (2013) proposed that better understanding patient portal 
benefits would require studies that include details about context (e.g., evidence on health 
outcomes, satisfaction, efficiency, and attitudes), implementation factors (e.g., how patients are 
educated about the portal), and costs.  
Ultimately, this literature review indicates that there is a larger group of researchers who 
agree on the benefits and promises of portals, but that others are more critical and take the 
position that their benefits are still unproven and their association with patient outcomes is 
unclear. Low portal use represents a key challenge for all researchers and must increase before 
correlations between the patient portal and improved clinical outcomes can be thoroughly 
assessed. 
Discussion 
The literature published on patient engagement and SM through the patient portal has 
grown exponentially in recent years and this review only highlights a small portion of those 
studies. In spite of the volume of publications, the continually low adoption and usage rates 
described coupled with the rise in chronic diseases suggest that this topic has not been 
sufficiently addressed to date.  Given the literature, it appears that portal benefits may be 
measured as fewer missed appointments (i.e. no-shows and or same-day cancellations). These 
measures may be relevant to both patients and medical care practitioners since missed 
appointments have long been identified as common barriers to chronic disease management 
(Daggy et al., 2010; Gellad, Hass, & Safran, 2011). From a patient perspective, a missed 
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appointment is associated with poorer outcomes and increased emergency room visits (Samuels 
et al., 2015). From the provider perspective, missed appointments can result in lost revenue, 
decreased productivity, increased costs, and disruption of the patient-physician relationship 
(Samuels et al., 2015). Hwang et al. (2015) argued that missed appointments, and no-shows 
specifically, are also an important indicator of inferior primary care outcomes and suboptimal 
utilization. Meanwhile, Currie et al. (2012) found that T1DM and T2DM patients who missed 
appointments were at an increased risk of all-cause mortality.  
Factors contributing to missed appointments 
Missed appointment rates for diabetic patients vary from 4 to 40% (Turkcan et al., 2013). 
Several authors have sought to better understand the reasons for patients’ missed appointments, 
including: transportation issues, high healthcare costs, logistic constraints (childcare/work), 
feeling better, feeling too bad to leave home, a perceived lack of respect from doctors and clinic 
staff, anxiety about their illness, and personal and family issues (Dumontier, Rindfleisch, 
Pruszynski, & Frey, 2013; Vijayan, 2014). However, the most common reason cited by patients 
is that they simply forgot (Akhter, Dockray & Simmons, 2012; Arora et al., 2015; Kaplan-Lewis 
& Percac-Lima, 2013).  
Diabetic patients are often no exception. For instance, Akhter et al. (2012) used a 
telephone survey to ask T1DM patients who frequently missed appointments how their 
attendance could be improved, and these patients indicated that sending appointment reminders 
not too far in advance would be helpful. Their findings suggest improving the administrative 
approach to patients’ appointments’, reminding them in advance and improving communication 
between staff and patients. (Akhter et al., 2012).  
As a result, many healthcare organizations have implemented reminder practices 
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designed to reduce missed appointments. Some authors found mobile phone text message 
reminders were a cost-effective way of doing so (Brannan, Dewar, Taggerty, & Clark, 2011; 
Taylor, Bottrell, Lawler, & Benjamin, 2012). However, a more recent study by Kheirkhah et al. 
(2016) conducted at the U.S. Veterans Health Administration (VHA) found that both phone and 
text reminder systems have shown only modest improvements in no-show rates. Rai et al. (2011) 
argued that organizations must nonetheless have interventions to effectively reach out to patients 
with gaps in care and remind them of their appointments. Otherwise, many patients will at best 
delay treatment and at worst not seek treatment at all; and over time other interventions to reduce 
diabetes-related complications may be in vain (Nuti et al., 2015). Parker et al. (2012) therefore 
suggested that interventions that may address poor appointment keeping deserve special attention 
(p. 590). Consequently, while patient portals and the appointment reminders that stem from them 
may not address all of the factors associated with missed appointments, they can address one of 
the most important: forgetting (Horvath et al., 2011; Markowitz, Volkening, and Laffel, 2014). 
This potential represents a real opportunity.  
Summary 
Since many studies indicate that providers may hold the key to increasing patient portal 
adoption and use, this study may also help address some of the barriers associated with portal 
endorsement. Most providers can agree that regardless of their position on technology, missed 
appointments are a long-standing challenge in the healthcare industry (Samuels et al., 2015). 
Therefore, more providers may be more apt to rally around the idea of the portal and endorse it if 
it proves an effective way to decrease these events. This study adds to the current body of 
research by demonstrating which patients are more likely to use patient portals in a chronically 
ill population. In addition, it addresses two common issues that were described in the literature – 
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1) the importance of provider endorsement (Ancker et al., 2011; Irizarry et al., 2015; Ronda et 
al., 2015) and 2) the need to demonstrate how the portal can improve outcomes, costs, and 
utilization. This study is important because improving population health necessitates that we 
























A retrospective observational chart review was used to address the following research 
questions: 
1. What are the demographic profiles of MyChart® users?  
2. What demographic characteristics predict MyChart® use? 
3. Does MyChart® use predict overall no-show percentage? 
4. Is there a difference in patients’ missed appointment percentage when they have 
an activated MyChart® account compared to when they do not?  
The study design was selected because it addresses the research questions and may pave 
the way for future research that is not possible without a randomized prospective study. For the 
primary and secondary research questions, the relationship between MyChart® use and missed 
appointments, it is hypothesized that no-show percentages are associated with MyChart® use. 
Further, it is hypothesized that when patients activate a portal account before an appointment, 
and therefore receive email reminders of their upcoming visit, their missed appointment 
percentage is reduced.  
Setting 
The study was conducted at the Medical University of South Carolina (MUSC), a large 
academic health science center that maintains a 700-bed medical center (MUSC Health) and 
hosts more than one million patient visits on an annual basis (About MUSC, n.d.). The 2010-
2015 MUSC Health Strategic Plan outlined seven strategies to help MUSC become a top 25 
academic medical center by 2015 (MUSC Health Strategic Plan, n.d.). One strategy related to 
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Health Information Technology (HIT) was integrating the outpatient and inpatient Electronic 
Health Record (EHR) systems, thus improving communication, collaboration, and coordination 
of care. Accordingly, on July 1, 2014, MUSC implemented an enterprise-wide EHR software 
solution, Epic®.  
The primary goal of the Epic® EHR implementation was to establish a “one patient, one 
record” solution that assimilated the inpatient and outpatient systems, thereby accomplishing a 
health-IT related strategic goals. Additionally, the new Epic® EHR enabled MUSC to satisfy a 
“meaningful use” requirement stipulated by the Health Information Technology for Economic 
Clinical Health (HITECH) Act that requires EHR technology to be certified.  
Study Population  
This study included all MUSC adult patients with diabetes on the MUSC Diabetes 
Registry who a) had an appointment scheduled with one of MUSC’s in-network primary care 
providers (PCP’s) between July 1, 2014 and June 30, 2015 (the study period) and b) had records 
available in the Epic® EHR. Six inclusion criteria are established to determine whether a patient 
is included in the MUSC Diabetes Registry. Patients were included if they met any of the first 
three criteria and each of the last three criteria.  
1. Patient had a diabetes diagnosis in the Epic® EHR problem list, which includes 
current or recent medical complaints, issues, or diagnoses recorded by a provider 
2. Patient was seen for an appointment and the provider listed a diabetes diagnosis 
found in the diabetes grouper (i.e. a collection of diagnoses codes that relate to 
each other clinically) for the visit 
3. An invoice was generated to the patient or a third party payer with a diagnosis 
found in the diabetes grouper 
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4. Patient was 18 or older 
5. Patient’s status was not deceased 
6. Patient was not flagged as a test (i.e. fictitious) patient that was created and used 
in the Epic® EHR to allow for workflow and functionality testing.  
Nuti et al. (2015) indicated that primary care practices are the main source of healthcare 
for most patients with diabetes. Accordingly, patient records were selected on the basis of the 
patient having a primary care provider (PCP) within the MUSC Network during the study period. 
This criterion helps minimize the risk of including participants seeking care at MUSC for reasons 
other than diabetic care (e.g. orthopedics).  
The study population was refined by the following exclusion criteria: patients who had a 
pregnancy due date anytime in the future and patients over 80 years of age. The exclusion 
criteria were designed to remove individuals with gestational diabetes. Additionally, excluding 
patients over 80 years of age helps mitigate the risk of this subset of patients becoming 
identifiable, which can occur when specific criteria are applied to small populations.  
 After inclusion and exclusion criteria were employed, patients were grouped according to 
their MyChart® account use. Patients who activated their account and logged on two or more 
times during the study period were classified as MyChart® users, an approach consistent with 
recently published studies (Jones et al., 2015; Ronda et al., 2015). Patients who did not activate 
an account, or who activated an account but did not log on at least twice during the study period, 
were classified as nonusers. This classification is important because this study sought to define 
the profiles of active users, not just those who activate an account. Relatedly, since MyChart® 
users logged in two or more times during the study period, a stronger case may be made that use 
(not simply enrollment) is an important influence on patient arrivals. This classification 
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represents a key difference between this research and Horvath et al. (2011).  
Intervention (MyChart® Patient Portal)  
Within Epic® is a comprehensive patient web-portal called MyChart® (Figure 1). The 
portal represents the process dimension in Ryan & Sawin’s IFSMT theory.  
 
Figure 1: MyChart® patient portal  
MyChart® enables patients to engage in their care (e.g. examine test results, refill and 
renew medications, and send a secure message to their doctor’s office) voluntarily and at no cost. 
Access to information is controlled through secure activation codes, personal usernames, and 
passwords (MyChart®, 2013). Patients who wish to sign up for an account are issued an 
activation code during their clinic visit. Alternatively, patients can register for an account online 
or by calling MUSC. Once the request is processed, patients are emailed an activation code and 
instructions for completing the registration process. Activation codes expire after 30 days and are 
no longer valid after the first use (MyChart®, 2013).  
A key function of MyChart® is that patients can schedule, view, and cancel appointments. 
All primary care clinics provide patients the option to schedule an appointment by sending a 
secure message to their provider. However, some clinics also allow patients to schedule 
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themselves through the portal. All MyChart® enrollees receive an email confirming their 
appointment the day it is scheduled, another reminder approximately one week prior to the 
appointment, and an additional reminder at approximately 48 hours prior to the appointment.  
Outcomes 
The outcome measures formulated for the purposes of this study are no-shows (primary) 
and same-day cancellations (secondary). A no-show is defined in this study as a scheduled 
appointment that a patient missed without providing any prior notice. A same-day cancellation is 
defined as an appointment that a patient cancelled within 24 hours of the scheduled time.   
Data Set Description 
After regulatory and ethics approval from the MUSC Institutional Review Board, a de-
identified dataset was requested from the Epic® Research Team. The data was provided by 
MUSC’s Honest Broker and comprised two datasets (one containing patient-level demographic 
information and the other containing appointment level information). The datasets were linked 
by a “dummy” (e.g. pseudo) identifier assigned by the Epic® Research Team, a protocol 
consistent with the requirements for an exempt study.  
Definition of Variables 
Patient demographics 
The following demographic variables were collected for each patient: race (Black/non-
Black), marital status (married/not married), gender (male/female), smoking status (smoker/non-
smoker), and comorbidities (specifically, whether (yes/no) the patient had hypertension, 
hyperlipidemia, and/or obesity). Patient age was also collected and considered continuous. 
MyChart® factors obtained in the demographic dataset included whether the patient had an 
activated account (yes/no) as well as whether the patient “used” the account (yes/no). As 
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previously discussed, use in this study is defined as having logged on to the portal two or more 
times during the study period.  
For demographic comparisons between groups, patients were classified into one of two 
categories:  
(1) MyChart® nonuser (i.e. does not have an activated account or has an activated 
account [MyChart® enrollee] but has not logged on to the portal two or more times during the 
study period),  
(2) MyChart® user (i.e. has an activated account and has logged on to the portal two or 
more times during the study period). 
Patients will be categorized based on their MyChart® activation and “use” status as of 6/30/15.  
Appointment demographics 
Pertinent appointment data was also captured in a longitudinal dataset: the number of 
PCP appointments for each patient, the status of the appointment (arrived, no-showed, or 
cancelled), and whether the patient had an activated MyChart® account (i.e. MyChart® enrollee) 
at the time of each appointment (yes/no). Cancellations were further classified to identify those 
that occurred within 24 hours of the scheduled appointment time (i.e. same-day cancellations). 
As a longitudinal dataset, the MyChart® activation status was assessed at the time of each 
appointment throughout the one year study period (July 1, 2014 to June 30, 2015). However, 
“use” was not determined at the time of each appointment—only on June 30, 2015, the end of 
the reporting period.  
Data Analysis Plan 
The analysis of Epic® EHR data employed a combination of univariate, bivariate, and 
multivariate techniques. The study’s unit of analysis was patients. Initially, the demographic 
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profiles of MyChart® users, nonusers, and enrollees were compared. In addition, the 
characteristics of patients who use MyChart® were predicted. Subsequently, the primary and 
secondary research questions, the relationships between portal use and missed appointments (no-
shows and same-day cancellations), were examined. All statistical analysis and data management 
were performed using SPSS®  
 The demographic profiles of MyChart® enrollees, users, and nonusers were compared 
using descriptive statistics. Frequency and percentage distributions were calculated on each 
categorical demographic variable obtained from the Epic® EHR, while the mean and standard 
deviation were calculated for patient age, the only continuous demographic variable. The 
bivariate and multivariate analyses only analyzed MyChart® users and nonusers. It is important 
to note that some patients who were classified as nonusers may also be MyChart® enrollees, but 
since they did not use the portal at least two times during the study period, they were not 
distinguished in this study.  
To test for statistically significant relationships between MyChart use® ((dependent 
variable (DV)) and each categorical patient-level demographic variable (independent variables 
(IVs)) previously described, cross-tabulation and chi-square tests were conducted. Chi-square 
was selected because both the IVs and DV were categorical. To evaluate the significance of the 
results, the chi-square coefficient (x2) was compared to an expected frequency table. Any p-
values less than or equal to .05 were deemed statistically significant. When the calculated x2 
value was larger than the expected value, the null hypothesis (H0) was rejected. Rejecting the 
null hypothesis resulted in accepting the alternative hypothesis (HA), indicating that the IVs 
described were statistically significant to MyChart® use in an adult diabetic population. An 
independent t-test was conducted to determine whether a statistically significant difference 
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existed between the two groups (MyChart® users and nonusers) with respect to age. Again, the 
significance value was set at p ≤ .05. The table below shows the hypotheses tested.  
H01: MyChart® use (DV) is not associated with 
race (IV) among patients with diabetes. 
HA1: MyChart® use (DV) is associated with 
race (IV) among patients with diabetes. 
H02: MyChart® use (DV) is not associated with 
marital status (IV) among patients with 
diabetes.   
HA2: MyChart® use (DV) is associated with 
marital status (IV) among patients with 
diabetes.   
H03: MyChart® use (DV) is not associated with 
gender (IV) among patients with diabetes. 
HA3: MyChart® use (DV) is associated with 
gender (IV) among patients with diabetes. 
H04: MyChart® use (DV) is not associated with 
smoking status (IV) among patients with 
diabetes. 
HA4: MyChart® use (DV) is associated with 
smoking status (IV) among patients with 
diabetes. 
H05: MyChart® use (DV) is not associated with 
hypertension (IV) among patients with 
diabetes. 
H05: MyChart® use (DV) is associated with 
hypertension (IV) among patients with 
diabetes. 
H06: MyChart® use (DV) is not associated with 
hyperlipidemia (IV) among patients with 
diabetes. 
H06: MyChart® use (DV) is associated with 
hyperlipidemia (IV) among patients with 
diabetes. 
H07: MyChart® use (DV) is not associated with 
obesity (IV) among patients with diabetes. 
H07: MyChart® use (DV) is associated with 
obesity (IV) among patients with diabetes. 
H08: There is no difference in the mean age 
(DV) between MyChart® users and nonusers 
(IV) 
H08: There is a statistically significant 
difference in the mean age (DV) between 
MyChart® users and nonusers (IV) 
  
Binary logistic regression was then used to predict a patient’s decision to enroll in 
MyChart®. The DV was coded as 1 for patients who used MyChart® and 0 for patients who did 
not. The independent variables for the regression model were coded as follows: sex (0=male, 
1=female) marital status (not married=0, married=1) smoking status (non-smoker=0, smoker=1), 
race (non-Black=0, Black=1), whether the patient had hypertension (0=no, 1=yes), whether the 
patient had hyperlipidemia (0=no, 1=yes), whether the patient had obesity (0=no, 1=yes), and 
average age.  Binary logistic regression was selected because the DV (i.e. whether the patient 
uses MyChart®) can only have one of two outcomes (yes/no).  Logistic regression (logit 
command) was used to sort out the independent effects of each demographic variable. Significant 
coefficients were identified where p ≤.05. The odds ratio or Exp(b) provides the odds of a change 
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in the DV that occur with a one unit increase in the predictor variable. The following hypotheses 
were tested: 
H09: Race (IV) does not predict MyChart® use 
(DV) among patients with diabetes. 
HA9: Race (IV) predicts MyChart® use (DV) 
among patients with diabetes. 
H010: Marital status (IV) does not predict 
MyChart® use (DV) among patients with 
diabetes.   
HA10: Marital status (IV) predicts MyChart® 
use (DV) among patients with diabetes.   
H011: Gender (IV) does not predict MyChart® 
use (DV) among patients with diabetes. 
HA11: Gender (IV) predicts MyChart® use 
(DV) among patients with diabetes. 
H012: Smoking status (IV) does not predict 
MyChart® use (DV) among patients with 
diabetes. 
HA12: Smoking status (IV) predicts MyChart® 
use (DV) among patients with diabetes. 
H013: Hypertension (IV) does not predict 
MyChart® use (DV) among patients with 
diabetes. 
HA13: Hypertension (IV) predicts MyChart® 
use (DV) among patients with diabetes. 
H014: Hyperlipidemia (IV) does not predict 
MyChart® use (DV) among patients with 
diabetes. 
HA14: Hyperlipidemia (IV) predicts MyChart® 
use (DV) among patients with diabetes. 
H015: Obesity (IV) does not predict MyChart® 
use among patients with diabetes. 
HA15: Obesity (IV) predicts MyChart® use 
among patients with diabetes. 
H016: Age (IV) does not predict MyChart® use 
among patients with diabetes 
HA16: Age (IV) predicts MyChart® use among 
patients with diabetes 
 
By linking the appointment data to the patient demographic data, additional descriptive 
statistics were computed. Specifically, the mean number of appointments per patient and the 
average no-show and same-day cancellation percentage for each patient.  
Multiple linear regression analyses were used to determine whether a patient’s MyChart® 
user status significantly predicted overall no-show percentages, after controlling for all other 
demographic variables. Therefore, the linear regression model will illustrate which predictor 
variables best explain no-show percentages. Multiple linear regression was selected because the 
dependent variable is continuous (% no-show) and it was important to study the effect of 
multiple variables on the outcome, not simply MyChart® use. The following hypotheses were 
tested: 
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H017: MyChart® use (IV) does not predict 
no-show percentages (DV) among patients 
with diabetes.  
HA17: MyChart® use (IV) predicts no-
show percentages (DV) among patients 
with diabetes.  
 
Finally, to determine whether MyChart account activation at the time of appointment had 
any impact on the mean no-show and same-day cancellations (i.e. missed appointment) 
percentages, patients who activated a portal account during the study period were subjected to a 
within-subjects analysis. The number of no-shows and same-day cancellations were combined 
and classified as missed appointments. The percentage of missed appointments with an activated 
portal account and without an activated portal account was computed. Then, the differences in 
each patient’s mean missed appointment percentage pre and post portal activation was compared 
using a two-sided paired-samples t-test to determine the potential impact of portal activation. The 
paired-samples t-test was selected because the participants in the two groups (those with an 
activated account and those without) are the same. In this way, individual differences were not a 
factor as the test measures each patient’s missed appointment percentage before and after portal 
activation. The following hypotheses were tested:  
H018: An activated MyChart® account at the 
time of appointment has no impact on a 
patient’s missed appointment percentage.  
H018: An activated MyChart® account at the 
time of appointment does have an impact on a 
patient’s missed appointment percentage. 
 
Protection of Human Subjects 
The investigator successfully completed the Collaborative IRB Training (CITI) tutorial 
module (Group 2: Social & Behavioral Investigators & Key Personnel) prior to starting this 
research. To obtain approval for this study, an application was submitted electronically to the 
MUSC Institutional Review Board (IRB) through the organization’s eIRB website. The study 
was evaluated and approved in the Exempt research category in accordance with 45 CFR 
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46.101(b)(2). Once IRB approval was obtained, Epic® data was provided by MUSC’s Honest 
Broker. This process was facilitated by the completion of both a service request in SPARC 
(Services, Printing, & Application for Research Centers) and a Research Data Request form, as 
well as approval by the Research Team’s Data Review Committee.  
Limitations  
This research project may provide important insights into the use of the patient portal in a 
chronically ill population to improve missed appointments. However, there were six key 
limitations in this study. The most important limitation is related to the retrospective study 
design. Data was derived from the pre-existing medical records of patients with diabetes, which 
provides an inferior level of evidence when compared to a randomized, prospective study. 
Therefore, this study only identified associations and did not determine causality.  
The second limitation is the manner in which MyChart® use was defined. The goal was to 
define use by the number of log-ins as well as detailed information regarding how the patient 
used the portal (e.g., viewing lab results, scheduling an appointment, requesting a medication 
refill). Unfortunately, given time and resource constraints, a detailed review of the log files that 
contained this granular information was not feasible. Thus, use was defined as having logged on 
to the portal two or more times during the study period as previously explained.  
The third limitation associated with non-research oriented administrative records is that 
they are frequently incomplete or inaccurate. Accordingly, some demographic records contained 
missing data related to the patient’s comorbidities (hypertension, hyperlipidemia, and obesity). 
However, the number of records that contained missing data was limited to 42 records, so this 
issue did not pose serious problems for data analysis.  
The fourth limitation stems from the cross-sectional nature of the demographic dataset. 
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With demographic variables captured at one point in time, the end of the reporting period, there 
is always a risk that they may have changed during the study period.  
The fifth limitation is that the study results were drawn from primary care clinics within 
one academic medical center. Since the study involved a specific organization and group of 
chronically ill patients, it is uncertain whether the findings will generalize to other populations or 
settings 
Finally, the sixth limitation is selection bias given that the MUSC Diabetes Registry was 
sampled. In some cases, patients presenting to MUSC for the first time for non-diabetes related 
care (e.g. cancer) could indicate that they had diabetes and, thus, may or may not be included in 
the Diabetes Registry. If the diabetes diagnosis was not clinically confirmed by an MUSC PCP, 

















Who uses MyChart®? 
Demographic Characteristics of MyChart® Users 
During the study period (July 1, 2014 to June 30, 2015), 7,297 patients with diabetes 
scheduled 45,022 appointments (M=6.17 appts/pt, SD=4.524) with one of MUSC’s PCP’s. 
While all patients could activate an account during the study period, only a portion of them did.  
Of the 7,297 patients, 3,186 (43.7%) were considered MyChart® users, and thus they had an 
activated portal account and logged on two or more times during the study period. MyChart® 
users were significantly more likely to be female (55.2%), non-Black/African American (69.6%), 
married (65.1%), non-smokers (93%), and have at least one of the following comorbidities: 
hypertension (83.5%), obesity (76.1%), and hyperlipidemia (83.9%). The average age of portal 
users was 58.8 years (SD 12.2). The p-value in the bivariate analysis (i.e. chi-square tests and 
ttest) indicates that each demographic variable is statistically significant to MyChart® use (p 
≤.05). Accordingly, the null hypotheses (H01- H08) can be rejected and the alternative hypotheses 
accepted (Ha1-Ha8), indicating that each demographic variable has a relationship with portal use. 
The overall missed appointment rate (no-shows and same-day cancellations) for both MyChart® 
users and nonusers combined was 17%, consisting of 9.2% (4,171/45,022) no-shows and 7.7% 
(3,499/45,022) same-day cancellations. The average no-show rate was significantly lower for 
patients who used the portal (4.7%) compared to patients who did not (12.4%) (t(7295) =19.949, 
two-tail p=.000). The average same-day cancellation rate was only slightly lower, yet statistically 
significantly different, for portal users (5.3%) compared to nonusers (6.7%) (t(7295) =5.100, 
two-tail p=.000). See Table 1 for demographic comparisons between users and nonusers.  
 58 
Demographic Characteristics that Predict MyChart® use 
A binomial logistic regression was conducted to determine whether the demographic 
characteristics have any relationship to a patient using MyChart® (DV). The number of 
observations was 7,295, reduced by two from the 7,297 study population to remove patients who 
did not have each comorbidity denoted in the Epic® EHR. The Omnibus Tests of Model 
Coefficients was statistically significant (x2 (8)=1552.34, p≤.000), which indicates that adding 
the demographic variables to the model increased its predictive power. Including the predictor 
variables resulted in correctly classifying the outcome for 70.5% of cases compared to 53.3% in 
the constant only model. The Nagelkerke R2 value was .257, indicating that only 25.7% of the 
variance in MyChart® use is explained by the variance in the demographic variables. Therefore, 
there are many other variables not in our model which influence whether a patient will use the 
portal.  
The results of the logistic regression model indicate that with the exception of 
hypertension, which has a significance value of .152, all demographic characteristics analyzed 
significantly predicted MyChart® use (Table X, all p ≤.05). Therefore, patients who are female, 
married, and have comorbidities (specifically, hyperlipidemia and obesity) are significantly more 
likely to use MyChart®. Conversely, patients who are older, Black/African American, and 
smokers are significantly less likely to use the portal.  
The odds ratio (i.e. Exp(B)) indicates the odds that a patient will use MyChart® based on 
a change in the predictor variable. Therefore, when the predictor variable increases by one unit, 
the odds that MyChart® use can be predicted increase by the Exp(B) factor when all the other 
variables are held constant. For example, the odds ratio associated with marital status is 1.879. 
Accordingly, when a patient’s marital status changes from not married to married, they are 
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almost two times as likely or 88% more likely to use MyChart®. The odds ratio was also positive 
for sex (1.258), hyperlipidemia (1.298), and obesity (1.192). Therefore, females are 25.8% more 
likely than males to use the portal and patients with hyperlipidemia and obesity are 25.8% and 
19.2% more likely to use the portal.  
Likewise, the odds ratio associated with smoking status is .412, indicating that patients 
who smoke are more than half (41.2%) as likely to use MyChart® The odds ratio was also less 
than one for age (.966) and race (.184). Thus, for every one unit increase in a patient’s age, the 
likelihood that they will use the portal is decreased slightly (by .966 times), after controlling for 
the other factors in the model. Conversely, being Black/African-American considerably 
decreases the likelihood of portal use even after controlling for other demographic variables 
(Table 2).  
The Impact of MyChart® on Missed Appointments 
Factors that Predict No-Show Percentages 
A standard multiple linear regression analysis was conducted to test whether a patient’s 
MyChart® user status significantly predicted overall no-show percentages, after controlling for 
all other independent demographic variables. The regression model contained nine predictor 
variables MyChart® user [0=no, 1=yes], sex [0=male, 1=female] marital status [not married=0, 
married=1] smoking status [non-smoker=0, smoker=1], race [non-Black=0, Black=1], and 
comorbidities [0=no, 1=yes] and average age.  
Six of the predictor variables (age, marital status, smoking status, race, presence of 
hypertension, and MyChart® use) were significantly associated with no-show percentages (p 
≤.05). Smoking status (β=.034, p=.000) and race (β=.042, p=.000) positively and significantly 
predicted no-show percentages. Therefore, patients who smoke have a 3.4% higher no-show 
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percentage than non-smokers while holding all other variables constant. Similarly, Black/African 
Americans have a 4.2% higher no-show percentage than non-Black/African Americans. Age 
(β=-.002, p=.000), marital status (β=-.010, p=.013), and hypertension (β=-.015, p=.006) were all 
negatively and significantly correlated with no-show percentage. The odds ratio indicates that 
patients who are older have a .02% lower no-show percentage, those who are married have a 1% 
lower no-show percentage, and those with hypertension have a 1.5% lower no-show percentage. 
Most importantly, MyChart® use (β=-.062, p=.000) significantly predicted no-show percentage, 
indicating that patients who use the portal are 6.2% less likely to no-show. Neither sex (female) 
nor hyperlipidemia or obesity contributed to the regression model. The linear regression model 
used accounts for significantly more variance than would be expected by chance (i.e. with a 
constant only model). However, the overall model fit was R2=.113, suggesting that only 11.3% 
of the variance was explained by the model (Table 3).  
Within-subjects Analysis for Patients who activated MyChart® during the study period 
A paired-samples ttest was conducted to compare the mean percent of missed 
appointments (i.e. no-shows and same-day cancellation) before and after MyChart® activation. 
The results specified that for the 78 patients who activated a portal account during the study 
period, the mean percentage of missed appointments when patients had an activated account 
(M=23.12, SD=41.608) was not significantly different from when they had an inactivated 
account ((M=37.23, SD=47.933), t(77) =-1.658, two-tail p=.101). Therefore, patients’ missed 
appointment percentage does not significantly change when they activate an account and the 






Discussion of Results 
This study described the demographic characteristics of adult patients with Type 1 and 
Type 2 diabetes who actively used the MyChart® patient portal at MUSC. Remarkably, portal 
users comprised 43.7% (3,186/7,297) of the overall study population, a percentage far greater 
than the mere 5 to 10 percent of American adults previously reported to use portals (Abdouch, 
2015; Giardina, Modi, Parrish, & Singh, 2015) and in gross excess of Stage 2 MU requirements 
that require only one person seen during the reporting period to access the portal. This higher 
than average usage rate demonstrates that the patient portal is in fact a viable tool for engaging 
adult patients with diabetes in their own care. Portals may therefore provide a suitable strategy 
for keeping this growing population accountable and engaged in managing their health. As 
previously indicated, portal users were predominantly female, non-Black/African-American, 
non-smokers, married, and had hypertension, hyperlipidemia, and obesity. The average age of a 
portal user was 58.8 (SD=12.2) years and while statistically different, was rather comparable to 
nonusers whose average age was 61.6 (SD=12.2) years.  
Predictors of Portal Use in a Chronically Ill Population 
The predictors of portal enrollment and use in a chronically ill population have varied. 
Some studies have found that men are more likely to actively use the portal (Jones et al., 2015; 
Nijland et al., 2011; Ronda et al., 2015), while others have demonstrated that women are more 
likely (Fleming, Cullen, & Luna; 2015; Horvath et al., 2011; Kruse, Bolton, & Freriks, 2015). 
There have also been conflicts surrounding the age of EHR portal users, with some studies 
indicating that they are younger than the average population (Ronda et al., 2013; Tenforde et al., 
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2012) and others describing them as older (Ancker et al., 2011; Horvath et al., 2011). Many of 
those contradictions can likely be attributed to differences in the geographical locations where 
the studies were conducted, dissimilar healthcare organizations that served as the study setting, 
and diverse inclusion and exclusion criteria (e.g. some examined diabetic patients while others 
looked at patients with other chronic conditions). Nonetheless, for this study, gender, age, race, 
marital status, smoking status, and the presence of comorbidities often associated with diabetes 
(i.e. hypertension, hyperlipidemia, and obesity) all significantly predicted portal use.  
While some demographic factors are known confounders such as race and gender, the 
inclusion of marital status and smoking status in this study has not been widely studied in 
previous research. Married patients were significantly more likely to use the portal, lending 
credibility to previous findings indicating that family members’ involvement, in this case a 
spouse, may be a means to increase portal use (Mayberry et al., 2011; Mayberry et al., 2014). 
Similarly, those with comorbidities were more likely to use the portal as they likely have greater 
health needs. Smoking status was examined because MU requirements dictate that it be recorded 
in the EHR given the tremendous health risk smoking poses to patients. Unfortunately, smokers 
in the study were less likely to use the MyChart® patient portal which could help make the 
disease more challenging to control.  
Riippa, Linna et al. (2014) suggested that the “digital divide” between sociodemographic 
groups is narrowing as Internet access grows. However, consistent with other prior research, this 
study found tremendous racial disparities in portal use as only 30.3% of users were Black, 
compared to 69% of nonusers (Ancker et al., 2011; Goel et al., 2011; Sarkar et al., 2011). This 
finding is not trivial, since previous research has indicated that Blacks/African-Americans have a 
dramatically higher prevalence of diabetes with greater disease and mortality burdens compared 
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to non-Hispanic White Americans (Chow, Foster, Gonzalez, & McIver, 2012). Therefore, the 
same individuals who are less likely to use the patient portal are also more likely to have diabetes 
and suffer poor health outcomes from the disease. Accordingly, the portal may be useful in 
engaging chronically ill patients overall, but it is less advantageous in engaging minorities, and 
specifically Blacks/African-Americans. Greater understanding of the factors that influence racial 
minorities to engage in their care will be critical so that existing healthcare disparities are not 
further exacerbated.  
When predicting the demographic characteristics related to portal use, only a small 
portion of the variance (R2=.257) could be explained by the hypothesized logistic regression 
model. However, this finding was expected, as the literature indicates many different factors 
(e.g., literacy, numeracy, educational attainment) that must be considered when predicting portal 
use. Many of those variables were not evaluated in this study, and thus the low R2 value was not 
disappointing. The low R2 value does not change the importance of the p-values and odds ratios 
and thus important conclusions can still be drawn on the statistically significant predictors 
associated with a change in portal use.  
The Impact of MyChart® on Missed Appointments  
In other countries, where healthcare systems can differ significantly from the United 
States’, the issue of missed appointments has been discussed heavily with a variety of patient 
populations (Hung, Fu, Lau, & Wong, 2015; Jyun-You, Chia-Fen, & Chao-Yu, 2012; Khader et 
al., 2014; Masding et al., 2010; Snow & Fulop, 2012; Waqar et al., 2012). In the United States, 
Horvath et al. (2011) documented the portal as an effective tool for engaging patients and thus 
potentially reducing missed appointments.  
Differing from Horvath et al. (2011), the present study focused on a chronically ill 
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population who would likely derive the greatest benefit from greater appointment attendance. In 
this study, several demographic characteristics (i.e. smoking status, race, age, and marital status) 
were independent predictors of no-show percentages in the multiple linear regression model. Of 
concern was the discovery that Black/African-American patients were significantly more likely 
to no-show. With diabetes impacting minority populations more than Whites, Black/African-
American patients would likely benefit the most from the appointments they are missing.  
Most importantly, this study found that portal use was a significant predictor of no-show 
percentages even after controlling for each of the other demographic factors previously 
referenced. Therefore, the odds of no-showing were reduced by 6.2% when patients used 
MyChart® suggesting that the portal contributes to greater appointment adherence.  
The R2 value of the linear regression model was only .113, meaning that only 11.3% of 
the variance is explained by the model. With a wide variety of reasons contributing to missed 
appointments (e.g., transportation issues, childcare constraints, forgetting) and patients being 
relatively unpredictable, this finding was not surprising. Still, the p-value indicates a statistically 
significant relationship between the predictor variables (smoking status, race, marital status, age, 
and MyChart® use) and no-show percentages. The odds ratio remains the same as well, 
regardless of the R2 value, and suggests how the outcome variable (no-show percentages) 
responds with a one unit change in each significant predictor. That is for example, when a patient 
uses the portal, their no-show percentage is almost two times less than if they did not use the 
portal.  
The overall mean no-show percentage for patients who had an activated MyChart® 
account throughout the study period (and therefore at each PCP appointment) was significantly 
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lower (5.8%), when compared to those with an inactivated account (12.5%).2 For patients who 
activated a portal account during the study period, the mean percentage of missed appointments 
pre (M=23.12, SD=41.608) and post (M=37.23, SD=47.93) MyChart® activation were 
compared. Then the statistical significance of the differences was assessed with a “within-
subjects” analysis. Unfortunately, and contrary to expectations, the paired t-test did not show a 
statistically significant difference in the mean missed appointment percentage when patients had 
an activated account at the time of their appointment compared to when they did not. Therefore, 
patients’ missed appointment percentage did not significantly change when they activated an 
account, and the differences in the population means (M=-14.106) are likely due to chance. It is 
important to note that only 78 patients activated their portal account during the study period 
(2.4% of users), and some did not have a missed appointment (i.e. no-show or same-day 
cancellation) during the 12 month study period. While the p-value (.10) was very close to the 
significance value (.05), this finding corroborates what the previous multivariate analysis 
suggests: that the portal is only one component to appointment arrivals.  
Thus, this study validates that the portal is not only useful in engaging chronically ill 
patients, but those who use it have a lower appointment no-show percentage. With missed 
appointments posing pivotal barriers to effective chronic disease management, this outcome is 
invaluable. However, the change in mean missed appointment percentage was not statistically 
different when tested in a small subset of the study population. Accordingly, the patient portal, 
like any intervention involving patients, is only one element in the multifaceted patient 
                                                
2 Portal user status was only assessed at the end of the reporting period on 6/30/15. Use was defined by two or more log-
ins over the twelve month study period. Therefore when a patient is said to have an activated portal account at the time of 
their PCP appointment (assessed at each appointment), they may or may not be deemed a portal user as that information 
was not assessed at the time of each appointment (only whether they had an activated/inactivated account).  
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engagement solution.  
Conclusion 
The patient portal is one of many tools available to healthcare organizations striving to 
engage patients in their care. In this study, the portal’s value for engaging chronically ill patients 
was demonstrated. Specifically, this study indicates that patients with diabetes who use the portal 
are less likely to no-show for their primary care appointments. For patients who require routine 
follow-up, this finding is meaningful since previous research has associated clinic nonattendance 
with increased mortality in patients with Type 2 diabetes (Currie et al., 2012).  
As a retrospective observational study, the research was limited to the variables available 
for analysis. However, to effectively engage patients in the portal, thereby encouraging them to 
take a greater role in their health and wellbeing, healthcare organizations must thoroughly 
evaluate the many underlying factors that contribute to portal use. The findings in this study 
provide the foundational knowledge necessary to warrant further research, including randomized 
prospective studies. Randomized prospective studies would better assess the relationships 
between portal use and missed appointments and clarify causation more directly. Future studies 
could also expand to include other chronically ill populations (e.g. heart disease, cancer). Finally, 
cost was not evaluated in this study, but it is reasonable to assume that a certified EHR is not 
inexpensive. Hence, the benefits of portals at reducing missed appointments must be properly 
vetted against the cost of portal installation.  
Summary 
Across the United States, healthcare organizations are striving to reduce costs, enrich 
their quality of care, enhance patient satisfaction, and most importantly improve population 
health. For a country that is profoundly encumbered by chronic health issues, efforts to improve 
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healthcare delivery will be stifled if they do not center on reducing the burden of disease. More 
plainly, the United States is in the midst of a health--not healthcare--crisis and patient 
engagement is of utmost importance. While the patient portal is only one tool for encouraging 
patients to take an active role in their health, this study has highlighted that it is an important one 






























Table 1. Characteristics of MyChart®  Users compared to Nonusers (Percentages in 
Parentheses) 














   Hypertension 
   Obesity 
   Hyperlipidemia 
 

































Mean No-show % 4.7 12.4 
 
a  Status as of 06/30/15 













Table 2: Logistic Regression Analysis predicting MyChart® use for patients with diabetes. 
Predictor	  Variablesd	   Bb	   Significancea	   Exp(B)c	  
Constant	   1.827	   .000	   6.218	  
Female	  (1)	   .229	   .000	   1.258	  
Age	   -­‐.034	   .000	   .966	  
Black/African-­‐American	  (1)	   -­‐1.692	   .000	   .184	  
Married	  (1)	   .631	   .000	   1.879	  
Smoker	  (1)	   -­‐.887	   .000	   .412	  
Has	  Hypertension	  (1)	   .113	   .152	   1.120	  
Has	  Hyperlipidemia	  (1)	   .261	   .001	   1.298	  
Is	  Obese	  (1)	   .176	   .006	   1.192	  
a The significance column indicates whether the coefficient is significantly different from 0. p-values less than or 
equal to .05 are deemed statistically significant. With the exception of hypertension, all predictors are significant to 
MyChart® use.  
 
b  This column describes the amount of increase or decrease expected in the dependent variable (MyChart® use 
coded as 0=nonuser and 1=user) that would be predicted by a 1 unit increase/decrease in each predictor variable. 
Since the column is represented in log-odds units, it can be difficult to interpret, thus the values are converted to 
odds ratios in the Exp(B) column. 
 
c The Exp(B) (odds ratio) column describes the amount of change in the DV expected from a one unit 
increase/decrease in the predictor variable. For example, marital status is a categorical variable coded as (0=not 
married and 1=married). Therefore, when all other variables are held constant, patients who are married are 87.9% 
more likely to use the portal when compared to patients who are not married. The odds ratio is also positive for sex, 
hyperlipidemia, and obesity and negative for age, race, and smoking status.  
 
d With the exception of age, each of the predictor variables are categorical. The reference group is coded as 0 and the 
alternative is coded as 1. For example, smoking status is coded as (0=non-smoker and 1=smoker). The reference 
category for each of the other categorical variables is (0 = male, non-Black, not married, does not have hypertension, 



















Table 3: Linear Regression Model predicting No-show percentages 
 
Predictor	  Variables	   Unstandardized	  B	  Coefficientsb	   ta	   Significancea	  
Constant	   .255	   20.897	   0.000	  
Sex	   -­‐.007	   -­‐1.768	   0.077	  
Age	   -­‐.002	   -­‐12.369	   0.000	  
Race	   .042	   10.008	   0.000	  
Marital	  Status	   -­‐.010	   -­‐2.496	   0.013	  
Smoking	  Status	   .034	   5.692	   0.000	  
Has	  Hypertension	   -­‐.015	   -­‐2.766	   0.006	  
Has	  Hyperlipidemia	   -­‐.014	   -­‐2.581	   0.010	  
Is	  Obese	   .001	   0.296	   0.767	  
Uses	  MyChart®	   -­‐0.062	   -­‐15.003	   0.000	  
a The t and significance columns indicates whether the coefficient is significantly different from 0. p-values less than 
or equal to .05 were deemed statistically significant. Age, race, marital status, smoking status, has hypertension, and 
MyChart® use were all significantly associated with no-show percentages. Sex, hyperlipidemia, and obesity did not 
contribute to the model.  
 
b The unstandardized B coefficient provides the values for the regression equation for predicting the DV from the 
IV. The coefficient for MyChart use® is -.062. Thus when a patient converts from a nonuser to user, they are 6.2% 



























Table 4: Within-subjects comparison: Paired samples t-test comparing mean missed 
appointment percentage between those with and without an activated MyChart® account  
 
      Groups   
  
 
With MyChart® Without MyChart® 
  n Ma SDb M SD 
Missed Appointment Percentage 78 23.12 41.608 37.23 47.933 
  
    
  
  dfc M SD t Significanced 
Paired Differences 
(with/without MyChart®) 77 -14.106 75.117 -1.658 0.101 
aM=Mean 
bSD=Standard Deviation 
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